Literature DB >> 25907220

Replication stress and cancer.

Hélène Gaillard1, Tatiana García-Muse1, Andrés Aguilera1.   

Abstract

Genome instability is a hallmark of cancer, and DNA replication is the most vulnerable cellular process that can lead to it. Any condition leading to high levels of DNA damage will result in replication stress, which is a source of genome instability and a feature of pre-cancerous and cancerous cells. Therefore, understanding the molecular basis of replication stress is crucial to the understanding of tumorigenesis. Although a negative aspect of replication stress is its prominent role in tumorigenesis, a positive aspect is that it provides a potential target for cancer therapy. In this Review, we discuss the link between persistent replication stress and tumorigenesis, with the goal of shedding light on the mechanisms underlying the initiation of an oncogenic process, which should open up new possibilities for cancer diagnostics and treatment.

Entities:  

Mesh:

Year:  2015        PMID: 25907220     DOI: 10.1038/nrc3916

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  198 in total

1.  Collisions between replication and transcription complexes cause common fragile site instability at the longest human genes.

Authors:  Anne Helmrich; Monica Ballarino; Laszlo Tora
Journal:  Mol Cell       Date:  2011-12-23       Impact factor: 17.970

2.  Genetic instability and mammary tumor formation in mice carrying mammary-specific disruption of Chk1 and p53.

Authors:  T Fishler; Y-Y Li; R-H Wang; H-S Kim; K Sengupta; A Vassilopoulos; T Lahusen; X Xu; M-H Lee; Q Liu; S-J Elledge; T Ried; C-X Deng
Journal:  Oncogene       Date:  2010-05-17       Impact factor: 9.867

3.  Excess MCM proteins protect human cells from replicative stress by licensing backup origins of replication.

Authors:  Arkaitz Ibarra; Etienne Schwob; Juan Méndez
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-25       Impact factor: 11.205

4.  c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells.

Authors:  Zuqin Nie; Gangqing Hu; Gang Wei; Kairong Cui; Arito Yamane; Wolfgang Resch; Ruoning Wang; Douglas R Green; Lino Tessarollo; Rafael Casellas; Keji Zhao; David Levens
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

5.  RECQ1 is required for cellular resistance to replication stress and catalyzes strand exchange on stalled replication fork structures.

Authors:  Venkateswarlu Popuri; Deborah L Croteau; Robert M Brosh; Vilhelm A Bohr
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

6.  Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice.

Authors:  Scott Houghtaling; Cynthia Timmers; Meenakshi Noll; Milton J Finegold; Stephen N Jones; M Stephen Meyn; Markus Grompe
Journal:  Genes Dev       Date:  2003-07-31       Impact factor: 11.361

Review 7.  How the fanconi anemia pathway guards the genome.

Authors:  George-Lucian Moldovan; Alan D D'Andrea
Journal:  Annu Rev Genet       Date:  2009       Impact factor: 16.830

8.  FBH1 promotes DNA double-strand breakage and apoptosis in response to DNA replication stress.

Authors:  Yeon-Tae Jeong; Mario Rossi; Lukas Cermak; Anita Saraf; Laurence Florens; Michael P Washburn; Patrick Sung; Carl L Schildkraut; Carl Schildkraut; Michele Pagano
Journal:  J Cell Biol       Date:  2013-01-14       Impact factor: 10.539

9.  Essential developmental, genomic stability, and tumour suppressor functions of the mouse orthologue of hSSB1/NABP2.

Authors:  Wei Shi; Amanda L Bain; Bjoern Schwer; Fares Al-Ejeh; Corey Smith; Lee Wong; Hua Chai; Mariska S Miranda; Uda Ho; Makoto Kawaguchi; Yutaka Miura; John W Finnie; Meaghan Wall; Jörg Heierhorst; Carol Wicking; Kevin J Spring; Frederick W Alt; Kum Kum Khanna
Journal:  PLoS Genet       Date:  2013-02-07       Impact factor: 5.917

10.  Mouse SLX4 is a tumor suppressor that stimulates the activity of the nuclease XPF-ERCC1 in DNA crosslink repair.

Authors:  Michael R G Hodskinson; Jan Silhan; Gerry P Crossan; Juan I Garaycoechea; Shivam Mukherjee; Christopher M Johnson; Orlando D Schärer; Ketan J Patel
Journal:  Mol Cell       Date:  2014-04-10       Impact factor: 17.970

View more
  324 in total

Review 1.  DNA replication stress: from molecular mechanisms to human disease.

Authors:  Sergio Muñoz; Juan Méndez
Journal:  Chromosoma       Date:  2016-01-21       Impact factor: 4.316

2.  A Genome-Wide Pooled shRNA Screen Identifies PPP2R2A as a Predictive Biomarker for the Response to ATR and CHK1 Inhibitors.

Authors:  Zhaojun Qiu; Pengyan Fa; Tao Liu; Chandra B Prasad; Shanhuai Ma; Zhipeng Hong; Ernest R Chan; Hongbing Wang; Zaibo Li; Kai He; Qi-En Wang; Terence M Williams; Chunhong Yan; Steven T Sizemore; Goutham Narla; Junran Zhang
Journal:  Cancer Res       Date:  2020-06-10       Impact factor: 12.701

3.  miR-1293, a Candidate for miRNA-Based Cancer Therapeutics, Simultaneously Targets BRD4 and the DNA Repair Pathway.

Authors:  Yuki Takagawa; Yasuyuki Gen; Tomoki Muramatsu; Kousuke Tanimoto; Jun Inoue; Hiroyuki Harada; Johji Inazawa
Journal:  Mol Ther       Date:  2020-04-11       Impact factor: 11.454

4.  Improved Antitumor Activity of the Fluoropyrimidine Polymer CF10 in Preclinical Colorectal Cancer Models through Distinct Mechanistic and Pharmacologic Properties.

Authors:  William H Gmeiner; Anthony Dominijanni; Alex O Haber; Lais P Ghiraldeli; David L Caudell; Ralph D'Agostino; Boris C Pasche; Thomas L Smith; Zhiyong Deng; Sezgin Kiren; Chinnadurai Mani; Komaraiah Palle; Jonathan R Brody
Journal:  Mol Cancer Ther       Date:  2020-12-23       Impact factor: 6.261

5.  TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas.

Authors:  Z Liu; K Yanagisawa; S Griesing; M Iwai; K Kano; N Hotta; T Kajino; M Suzuki; T Takahashi
Journal:  Oncogene       Date:  2017-02-13       Impact factor: 9.867

Review 6.  Genomic evolution of cancer models: perils and opportunities.

Authors:  Uri Ben-David; Rameen Beroukhim; Todd R Golub
Journal:  Nat Rev Cancer       Date:  2019-02       Impact factor: 60.716

Review 7.  Proteolytic control of genome integrity at the replication fork.

Authors:  Julie Rageul; Alexandra S Weinheimer; Jennifer J Park; Hyungjin Kim
Journal:  DNA Repair (Amst)       Date:  2019-07-10

Review 8.  Inside the hypoxic tumour: reprogramming of the DDR and radioresistance.

Authors:  Katheryn Begg; Mahvash Tavassoli
Journal:  Cell Death Discov       Date:  2020-08-18

9.  Transcription-Replication Conflict Orientation Modulates R-Loop Levels and Activates Distinct DNA Damage Responses.

Authors:  Stephan Hamperl; Michael J Bocek; Joshua C Saldivar; Tomek Swigut; Karlene A Cimprich
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

10.  The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor Mutations.

Authors:  Liang Chen; Jia-Yu Chen; Yi-Jou Huang; Ying Gu; Jinsong Qiu; Hao Qian; Changwei Shao; Xuan Zhang; Jing Hu; Hairi Li; Shunmin He; Yu Zhou; Omar Abdel-Wahab; Dong-Er Zhang; Xiang-Dong Fu
Journal:  Mol Cell       Date:  2018-01-27       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.